Skip to main content

Find Clinical Trials

Clinical trial condition

TNBC

Explore clinical trials studying TNBC. Study availability and eligibility vary by location and protocol.

15 public trials 8 recruiting studies

Refine in advanced search Browse all conditions

TNBC trial results

Not Yet Recruiting

A Single-Arm, Single-Center, Phase II Clinical Study of Camrelizumab Combined With Radiochemotherapy as Neoadjuvant Therapy for Early-Stage Triple-Negative Breast Cancer

NCT07491822

Conditions: TNBC
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Phase II, Single-arm Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Eribulin in Pretreated Advanced Triple-negative Breast Cancer Harboring a PIK3CA Mutation

NCT07441512

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Comparing UTD2 Combined With Capecitabine to Capecitabine as Adjuvant Therapy for Non-pCR TNBC Patients

NCT07021261

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Phase II Clinical Study to Evaluate the Safety, Pharmacokinetic Profile, and Preliminary Efficacy of IMM2510 in Combination with Chemotherapy As First-line Treatment in Subjects with Non-small Cell Lung Cancer or Triple-negative Breast Cancer

NCT06746870

Conditions: NSCLC, TNBC
Locations: Not specified

View Trial Details

Active, Not Recruiting

A Study of PM8002 Plus Nab-paclitaxel as First Line Therapy for TNBC

NCT05918133

Conditions: TNBC
Locations: The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China

Affiliated Cancer Hospital of Harbin Medical University Harbin, Heilongjiang, China

Jiangsu Province Hospital Nanjing, Jiangsu, China

Nanchang Third Hospital Nanchang, Jiangxi, China

View Trial Details